Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Plos Pathogens|April 4, 2022
NK cells and monocytes modulate primary HTLV-1 infectionRamona Moles, Sarkis Sarkis, Veronica Galli, et al.
Nature Communications|September 26, 2025
High expression of Rex-orf-I and HBZ mRNAs and bronchiectasis in lung of HTLV-1A/C infected macaquesSarkis Sarkis, Anna Gutowska, Mohammad Arif Rahman, et al.
JCI Insight|June 24, 2024
Innate protection against intrarectal SIV acquisition by a live SHIV vaccineYongjun Sui, Thomas J Meyer, Christine M Fennessey, et al.
Ebiomedicine|August 25, 2023
Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIVAdrienne E Swanstrom, Robert J Gorelick, Jorden L Welker, et al.
PNAS Nexus|July 25, 2022
An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaquesYongjun Sui, Jianping Li, Hanne Andersen, et al.
Vaccines|November 25, 2023
In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-CellsMassimiliano Bissa, Veronica Galli, Luca Schifanella, et al.
JCI Insight|April 28, 2021
Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaquesYongjun Sui, Jianping Li, Roushu Zhang, et al.
The Journal of Clinical Investigation|January 19, 2021
Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapyAdrienne E Swanstrom, Taina T Immonen, Kelli Oswald, et al.
Cell Reports. Medicine|June 16, 2026
Sustained mucosal delivery of SAMT-247 via an intravaginal ring reduces the risk of SIVmac251 acquisition in vaccinated macaquesMohammad Arif Rahman, Emmanuel K Woode, John A Moss, et al.
JCI Insight|June 7, 2019
TLR7 agonist administration to SIV-infected macaques receiving early initiated cART does not induce plasma viremiaGregory Q Del Prete, W Gregory Alvord, Yuan Li, et al.
Pageof 5